Drug Targets

Conferences & Courses
Next-Gen Kinase Inhibitors	Next-Gen Kinase Inhibitors
June 4-6, 2012 | Cambridge, MA
The kinase inhibitor field is maturing.

Targeting Parkinson's Disease Targeting Parkinson's Disease
June 4, 2012 | Philadelphia, PA
Cambridge Healthtech Institute’s Targeting Parkinson’s Disease meeting will meet June 4-5, 2012 in Philadelphia to address the key issues impacting current PD preclinical drug discovery.

Targeting Alzheimer's Disease Targeting Alzheimer's Disease
June 5-6, 2012 | Philadelphia, PA
Cambridge Healthtech Institute’s Successful Targeting of Alzheimer’s Disease meeting will meet June 5-6, 2012 in Philadelphia to address the key issues impacting current AD preclinical drug discovery.




Life Science Media Library
Translational Strategies for Development of Monoclonal Antibodies DVD Translational Strategies for Development of Monoclonal Antibodies DVD
May 8, 2011 |
This DVD covers the progression of “creating a best of breed informatics organization” from the basics of biology and genetics to application of semantic technologies. Through modeling, case studies, and best practice examples, participants will learn techniques on how to combine data in a meaningful way.
microRNA in Biomarker and Diagnostic Development DVD microRNA in Biomarker and Diagnostic Development DVD
March 28, 2011 |
Recorded during the microRNA in Biomarker and Diagnostic Development session at the Seventh Annual microRNA in Human Disease and Development meeting in Cambridge, MA, this DVD includes presentations covering the use of microRNAs to detect pathological conditions and diagnose malignancies, the impact of microRNAs on cancer treatment decision making and therapeutics, and information on microRNA deregulation in solid tumors.
Identification, Characterization & Targeting of Cancer Stem Cells DVD Identification, Characterization & Targeting of Cancer Stem Cells DVD
February 22, 2011 |
This short course reports on the considerable progress of identifying and validating specific targets on stem cells that are not present on other cells, and on specific therapeutics for these targets and for stem cell specific pathways that inhibit tumour growth and reduce CSC frequency. Moreover it covers new studies that focus on gene expression signatures revealing new therapeutic targets that are providing promising results in prostate cancers.




Publications, Reports, & Whitepapers
High-Content Analysis Report High-Content Analysis Report
High-Content Analysis: Technologies, Applications, and Market Dynamics, pubished by Insight Pharma Reports focuses on the applications, technology and market aspects of high-content analysis (HCA).
The PI3K/Akt/mTOR Pathway The PI3K/Akt/mTOR Pathway
The PI3K/Akt/mTOR Pathway: A Pipeline Analysis, published by Insight Pharma Reports.
Cytokine-Based Therapies and Inhibitors:R&D Pipelines, Markets, and Strategic Issues Cytokine-Based Therapies and Inhibitors:R&D Pipelines, Markets, and Strategic Issues
Emerging cytokine-based therapies, and inhibitors of cytokines and their receptors, represent attractive markets that have become highly competitive. More than 120 companies are developing over 270 new therapies that either are cytokines, mimic cytokines, or inhibit cytokines and/or cytokine receptors.














05.17.12
Featured Articles

Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.

Hosp Pract (Minneap). 2012 Feb;40(1):35-43

Authors: Lutz MA, Lovato P, Cuesta G

Abstract
OBJECTIVES: In Nicaragua, 30% of curre





Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.

Hosp Pract (Minneap). 2012 Feb;40(1):24-34

Authors: Lutz MA, Lovato P, Cuesta G

Abstract
O